This Grant will Fund the Company’s Translational Research Activities Through the Completion of a Pilot Clinical Trial. LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc., announced that it has been awarded ...
PORTAGE, Mich., Feb. 11, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of the T2 Alpha Humerus Nailing System, the latest addition to its T2 ...